The novel HLA-A*68:302 allele, identified by Sanger dideoxynucleotide sequencing in a Chinese individual.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
10 2023
Historique:
revised: 13 06 2023
received: 07 06 2023
accepted: 14 06 2023
medline: 5 9 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

HLA-A*68:302 differs from HLA-A*68:01:02:01 by one nucleotide in exon 4.

Identifiants

pubmed: 37403794
doi: 10.1111/tan.15139
doi:

Substances chimiques

HLA-A*68 antigen 0
Dideoxynucleotides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

517-519

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Barker DJ, Maccari G, Georgiou X, et al. IPD-IMGT/HLA database. Nucleic Acids Res. 2023;51(D1):D1053-D1060.
Marsh SG, Albert E, Bodmer W, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291-455.

Auteurs

Chun-Lin Gao (CL)

Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Department of Oncology, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Ke-Ming Du (KM)

Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.

Zhong-Zheng Zheng (ZZ)

Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.

Hui Bi (H)

Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Ze-Ping Zhou (ZP)

Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH